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tive effect on active maternal responsiveness (e.g., pup retrieval, pup 
licking, nest building) in postpartum rats. Acute administration of 
typical and atypical antipsychotics disrupts pup retrieval, pup lick-
ing, and nest building but not nursing in postpartum female rats 
(Giordano et al., 1990; Hansen et al., 1991a; Silva et al., 2001; Stern 
and Keer, 1999; Stern and Taylor, 1991). Animals under the influ-
ence of antipsychotics are slower to approach pups and retrieve 
fewer pups. They also spend less time licking their offspring and 
building the nest (Li et al., 2004a). Furthermore, novel antipsychot-
ics (e.g., amisulpride and aripiprazole) also exhibit a certain degree 
of inhibition on active maternal responses in a dose-dependent fash-
ion (Li et al., 2005a). Chronic treatment with haloperidol or olanzap-
ine via mini-pumps or repeated daily injections significantly inhib-
its rat active maternal behavior as well (Li et al., 2005b). It seems that 
the antipsychotic-induced disruption on pup retrieval, pup licking, 
and nest building may be an inherent feature of all currently avail-
able antipsychotics.
Although the antipsychotic-induced disruption on rat active 
maternal behavior is clear and robust, its underlying behavioral 
mechanism is not. Since maternal behavior has motivational as well 
as motor components, and given that antipsychotics (at least the typ-
1. Introduction
Clinical work on the mother-child relationship shows that the 
quality of maternal care from mothers with schizophrenia is gen-
erally inferior to that from healthy mothers and mothers with affec-
tive disorders (Bosanac et al., 2003; Wan et al., 2007). In comparison 
with healthy mothers and those with other mental disorders, schizo-
phrenic mothers are more remote, self-absorbed, intrusive, flaccid, 
insensitive and unresponsive, and less demanding when taking care 
of their infants (McNeil et al., 1985; Näslund et al., 1985; Persson-
Blennow et al., 1984, 1986; Riordan et al., 1999; Snellen et al., 1999; 
Wan et al., 2007). The speech of mothers with schizophrenia is less 
infant-focused, more negative, and with fewer songs and rhymes 
(Wan et al., 2008). Their infants are more avoidant (Riordan et al., 
1999). One important contributing factor for the disrupted mother-
infant interaction recognized by both patients and clinicians is antip-
sychotic medications (Awad, 1993; Awad and Hogan, 1994; Seeman, 
2004). Animal work also finds that a variety of antipsychotics, from 
typical (e.g., haloperidol) to atypical (e.g., clozapine, risperidone, 
olanzapine and quetiapine), to even more recent novel antipsychot-
ics (e.g., aripiprazole and amisulpride), possess a common disrup-
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Abstract
The behavioral mechanisms underlying antipsychotic-induced maternal behavior deficits were examined in the present study. 
Different groups of postpartum rats were treated with haloperidol (0.1 mg/kg), clozapine (10.0 mg/kg), chlordiazepoxide (5.0 
mg/kg, an anxiolytic) or vehicle (0.9% saline) on Days 4 and 6 postpartum and their maternal behaviors were tested under either 
pup-separation (e.g. pups were removed from their mothers for 4 h before testing) or no-pup-separation condition. Maternal 
behavior and drug-induced sedation were further tested for 3 days from Day 8 to 12 postpartum. Results show that pup-sep-
aration, which putatively increases maternal motivation, did significantly shorten clozapine-elongated pup approach latency, 
increase pup licking and nursing but fail to reverse the deficits in pup retrieval and nest building in the lactating rats treated with 
haloperidol and clozapine. Repeated haloperidol treatment produced a progressively enhanced disruption on pup retrieval and 
nest building and an attenuated sedation. In contrast, clozapine showed a progressively diminished disruption on pup retrieval 
and a concomitantly diminished sedative effect. Based on these findings, we suggest that antipsychotic drugs disrupt active 
maternal responses at least in part by suppressing maternal motivation, and drug-induced sedation also contributes to this dis-
ruptive effect, especially with clozapine.
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cutaneously, whereas CDP was administered intraperitoneally. We 
chose 0.1 mg/kg HAL and 10.0 mg/kg CLZ because these doses 
have been shown to effectively disrupt active maternal behavior (Li 
et al., 2004a). At the chosen doses, HAL and CLZ provided opamine 
D2 receptor occupancies in animals comparable to those observed 
in patients, approximately 50%-70% striatal D2 occupancy (Kapur et 
al., 2003). Thus, this dose selection enabled us to evaluate different 
drugs on a common ground at the clinically relevant dose. We also 
included CDP as a pharmacological control. CDP, like atypical CLZ, 
also gives rise to sedation (File, 1984) but lacks the antipsychotic 
effect. We chose 5.0 mg/kg CDP because it is an effective anxiolytic 
dose used in other behavioral models (Joordens et al., 1998; Klint, 
1991; Li et al., 2004b) and more importantly, its sedative effect shows 
a similar time course (File, 1984) to that of clozapine (Sanger,1985).
2.3. Basic experimental procedure
Starting 2 or 3 days prior to the first possible expected parturition 
date, the subjects were monitored every morning for signs of partu-
rition. Once the dam was found with pups in the morning (that day 
was designated as Day 1 postpartum), the mother was transferred 
into a clean cage with wood shavings for bedding. Two shredded 
paper towels were also provided for nesting material. The litter was 
culled to 8 pups (4 males and 4 females with the most visible milk 
bands). Maternal behavior tests were conducted from Day 4 to 12 
postpartum.
2.4. Maternal behavior test
Each test consisted of two phases. The first was a spot-check obser-
vation of maternal behavior under undisturbed condition. Using a 
laptop computer with an event recording program (J Watcher, http://
www.jwatcher.ucla.edu/), we recorded the location of mother rats 
and their pups and rated the quality of the nest on a 5-point scale 
according to the criteria of Lonstein and Fleming (2002). The second 
phase was an 8-min pup retrieval behavior test starting immediately 
after the first undisturbed test. This phase was initiated by taking 
the 8 pups away from the mother and destroying the nest. Ten sec-
onds later, the pups were placed in the corner of the cage diagonal 
to the nest site or dam sleeping corner. When the subject picked up a 
pup in her mouth and carried it back to the nest site, it was referred 
to as a successful pup retrieval. Approach latency was defined as the 
time taken form other rats to approach and sniff the pups from the 
reunion. First and last pup retrieval latency was defined as the time 
elapsed from the first pup approach to the retrieval of the first and 
eighth pup into the nest respectively. A score of 480 s was assigned to 
non-responders who did not approach or retrieve the testing pups. 
The total number of pups retrieved was recorded. The occurrence of 
other behaviors was also recorded, including pup nursing behavior 
(a rat positioning herself over the pups with legs splayed to accom-
modate the pups, including hover, high and low crouching over pos-
tures), pup licking (a female rat placing its tongue on the anogeni-
tal area and the rest of a pups body), nest building (a rat picking up 
nesting material in her mouth and transporting it back to the nest 
site or pushing the material with her forepaws toward the nest site). 
After the test, any unretrieved pups were returned to the nest site. 
The observers were unaware of the drug condition of each subject.
2.5. Experiment 1. Effects of pup-separation on the acute antipsychotic-
induced maternal behavior deficits
Four groups of postpartum rats (HAL- 0.1 mg/kg, CLZ- 10.0 mg/
kg, CDP- 5.0 mg/kg, and vehicle water, n = 12 per group for HAL, 
CLZ and vehicle; n = 10 for CDP) were used. On Day 4 postpartum, 
the first maternal behavior test started 0.5 h before drug injections 
(i.e., baseline). The second and third tests were carried out at 2 h and 
4 h after the drug or vehicle injection. We performed across-over 
ical ones) are known to produce motivational and motoric impair-
ments (Ikemoto and Panksepp, 1999; Salamone and Correa, 2002), it 
raises the question of whether this disruptive effect is motivational 
or simply motoric. In addition, because atypicals like clozapine and 
quetiapine also give rise to sedation due to their actions on hista-
mine H1 receptors and/or adrenergic receptors (Fleischhacker et al., 
1994), the atypical-induced disruption also could be attributed to 
drug-induced sedation.
The present study was designed to further investigate the behav-
ioral mechanisms underlying antipsychotic-induced disruption on 
rat maternal behavior. To address the motivational versus motoric 
issue, we employed a pup-separation technique. Previous studies 
show that removing pups from dams for several hours (>3 h) prior 
to maternal testing can significantly increase a mother rat’s mater-
nal motivation (Hansen, 1994). Three to six hours of pup deprivation 
can completely restore pup retrieval deficits induced by massive 
DA depletion in the ventral striatum region in postpartum female 
rats (Hansen, 1994). We treated our subjects with haloperidol and 
clozapine and tested them under the pup-separation (4 h) and no-
pup-separation condition. If pup-separation is able to antagonize the 
effect of antipsychotics, it would suggest that the disruptive drug 
effect is mainly exerted on animals’ motivation rather than on their 
motoric functions.
To examine to what extent antipsychotic drug-induced seda-
tion contributes to their disruption on active maternal behavior, 
we employed a repeated treatment schedule and compared effect 
of antipsychotics with that of chlordiazepoxide, an anxiolytic drug 
with a sedative effect (File, 1984). It is well known that with repeated 
drug administration, the sedative effect of antipsychotics and anx-
iolytics is greatly diminished (Chesler and Salamone, 1996), and 
tolerance can be seen with only four injections (File, 1984; Sanger, 
1985). In the meantime, antipsychotic efficacy is progressively 
enhanced with repeated drug administration (Agid et al., 2003; Li et 
al., 2007). If drug-induced sedation plays a role in disrupting active 
maternal behavior, we expect that the haloperidol- and clozapine-
induced maternal behavior deficits would show an improvement 
with repeated drug treatment. If this disruptive effect mainly reflects 
the effect of dopamine blockade (Li et al., 2004a), the haloperidol- 
and clozapine-induced deficits would persist and show a deteriora-
tion with repeated drug treatment.
2. Materials and methods
2.1. Subjects
Forty-six 2 or 3 month old pregnant female Sprague-Dawley rats 
purchased from Charles River Inc. (Portage, MI) or mated at the col-
ony were used in this study. All rats were housed individually in 
48.3 cm × 26.7 cm × 20.3 cm transparent polycarbonate cages under 
12-h light/dark conditions (light on between 6:30 am and 6:30 pm). 
The temperature-controlled colony was maintained at approxi-
mately 23°C. Experiments were conducted during the light cycle. 
The rats had free access to food and tap water in their home cages. 
All animal procedures were conducted in accordance to the National 
Institutes of Health Guide for the Care and Use of Laboratory Ani-
mals, and approved by the University of Nebraska Institutional Ani-
mal Care and Use Committee.
2.2. Drugs and choices of dosage 
The injection solutions of haloperidol (HAL, 5.0 mg/ml ampoules, 
Sabex Inc., Boucherville, Quebec, Canada) and chlordiazepoxide 
(CDP, Sigma-Aldrich, St. Louis, MO) were obtained by mixing the 
drugs with sterile water. Clozapine (CLZ, a gift from NIMH drug 
supply program) was dissolved in 1.0% glacial acetic acid in dis-
tilled water. HAL, CLZ, and vehicle water were administered sub-
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To examine the acute and chronic treatment effects, data were 
analyzed using a factorial repeated measures analysis of variance 
(ANOVA) with the between-subject fact or being the treatment con-
dition (HAL, CLZ, CDP and VEH) and the within-subject factors 
being the testing time points (e.g. baseline, 1 h, 2 h and 4 h) or days 
(Days 8, 10, and 12). Group differences were further investigated 
using simple main effect tests (one-way ANOVA) followed by LSD 
post hoc tests for multiple comparisons where appropriate. To exam-
ine the pup-separation effect, data from the Day 4 and Day 6 under 
the same testing condition (e.g. pup-separation on Day 4 and Day 6) 
were combined and analyzed using Paired-Samples T test.
For the latency and sedation data, because they were not normally 
distributed (e.g. the cut-off time set at 480 s for the latency data, 
and the sedation was ranking data), data for latency and sedation 
were displayed as median ± interquartile range. Nonparametric 
Kruskal-Wallis test was used for analyzing the difference between 
the drug treatment groups. Once the overall significant effects were 
determined, two-group comparisons between the drug and vehicle 
treatment were performed using Mann-Whitney U test. Separation 
effect was examined by comparing maternal behavior tested under 
the pup-separation condition with that tested under the no-separa-
tion condition using Wilcoxon Two Related-Samples tests. Correla-
tion between the disruptive effect on pup retrieval and sedation of 
the drugs was tested using Spearman’s rank correlation analysis to 
evaluate the possible influence of drug-induced sedation on mater-
nal behavior. A conventional two-tailed level of significance at the 
0.05 level was required.
3. Results
3.1. Experiment 1. Effects of pup-separation on the acute antipsychotic-
induced maternal behavior deficits
3.1.1. Acute haloperidol and clozapine treatment impaired active compo-
nents of maternal behavior
To identify the acute effect of antipsychotic treatment on maternal 
behavior, we examined maternal behavior of the four groups tested 
under the regular condition (no-pup-separation) on Day 4 postpar-
tum (see Figure 1). Consistent with our previous report (Li et al., 
2004a), a single injection of HAL and CLZ, but not CDP significantly 
(change-over) trial with variants of the two-treatment, two-period 
design. Half of the mother rats allocated at random to each group 
(n = 6 for HAL, CLZ and vehicle; n = 5 for CDP) were tested under 
the pup-separation condition in which their pups were taken away 
from them 4 h before the second test on that day. Pups were placed 
into a bowl with nesting material on a temperature-controlled heat-
ing pad (34°C). The other half of the mother rats were tested without 
separation from their pups (no-pup-separation condition). On Day 6 
postpartum, the same procedure was applied, but the rats started on 
the pup-separation condition on Day 4 started on the no-pup-sepa-
ration condition, and ones previously started on the no-pup-separa-
tion condition started on the pup-separation condition (a complete 
counter balanced design). This cross-over design allowed us to con-
secutively test each subject which received two experimental manip-
ulations during the course of the experiment. Various measures of 
maternal behavior were recorded (see below for testing details).
2.6. Experiment 2. Effects of repeated antipsychotic treatment on mater-
nal behavior in rats 
The above four groups of postpartum rats were used in this exper-
iment. After 2 days of rest, rats were treated with the same drug as 
before and tested on Days 8, 10 and 12 postpartum. On each drug 
test day, maternal behaviors were measured at 4 time points, with 
the first one at 0.5 h before the drug injections (i.e., baseline), and the 
rest at 1, 2, and 4 h after the drug injection. In addition to maternal 
behavior tests, the characteristics of sedation (e.g., eye closed, head 
down, curled up in a ball, flattened posture, ataxia, problems with 
limb placement, lack of alertness, general appearance of sleepiness) 
were concurrently observed. The sedative manifestations of mother 
rats were further assessed for 30-sec periods according to a sedation 
rating adapted from Chesler and Salamone (1996): 4 = awake, active: 
engaged in locomotion, rearing or head movement; 3 = awake, inac-
tive: eyes fully open, head up, no locomotion or rearing, normal 
posture; 2 = moderate sedation: eyes partly closed, head somewhat 
down; 1 = heavy sedation: eyes mostly closed, head mostly or entirely 
down, flattened posture, lack of normal limb placement; 0 = asleep.
2.7. Data analysis
Data for most maternal behaviors were presented as mean ± SEM. 
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Paired-Samples T test showed that separation significantly enhanac-
tivity across all four groups at the 2 h post-injection testing point (p 
< 0.01 for VEH, CDP; p < 0.05 for HAL, CLZ). It should be noted 
that although we used the combined data to examine the effects of 
pup-separation, the same results were obtained when the data from 
Days 4 and 6 postpartum were not combined and analyzed sepa-
rately.
3.2. Experiment 2. Effects of repeated antipsychotic treatment on mater-
nal behavior in rats
As can be seen in Figure 3, with repeated drug administration, 
HAL progressively enhanced its disruption on pup retrieval and 
maintained its disruption on pup approach, pup licking, and nest 
building. In contrast, CLZ showed a progressively attenuated dis-
ruption on pup approach and retrieval but maintained its disruption 
on pup licking and nest building.
3.2.1. Latency to approach and retrieve pups
With repeated drug administration, HAL produced persistent 
disruption of the pup approach latency and the first and last pup 
retrieval latency over 4 sessions across the three test days (data not 
shown), whereas CLZ exerted this disruptive effect at 1 h and 2 h 
(all p < 0.01) only on the first testing day. CDP treatment had no sig-
nificant effect on pup approach and pup retrieval latency (data not 
shown).
3.2.2. Pup retrieval
With repeated drug treatment, HAL progressively reduced the 
number of pups retrieved, whereas the disruptive effects of CLZ 
on this behavior were diminished. CDP had no significant effect in 
this regard. Repeated measures ANOVA revealed a significant main 
effect of drug treatment [F(3,40) = 4.16, p = 0.012 for baseline; F(3,40) = 
10.17, p < 0.001 for 1 h; F(3,40) = 11.28, p < 0.001 for 2 h; F(3,40) = 8.64, 
p < 0.001 for 4 h], no significant effect of test day, but a significant 
interaction between the two factors [F(6,80) = 1.21, p = 0.031 for base-
line; F(6,80) = 3.48, p = 0.004 for 1 h; F(6,80) = 7.06, p < 0.001 for 2 h; F(6,80) 
= 4.00, p = 0.001 for 4 h]. Post hoc tests showed that HAL significantly 
disrupted retrieval activity at 1 h, 2 h, and 4 h testing points (all ps < 
0.05) across the test days, even at the baseline on Day 10 postpartum 
(p = 0.030); whereas CLZ impaired pup retrieval at 1 h, 2 h, and 4 h 
post-injection testing points (all ps < 0.05) only on Day 8 postpartum. 
Additionally, Paired Samples T tests comparing the data on Day 8 to 
Day 12 postpartum showed that with repeated drug administration, 
the disruptive effect of HAL was progressively potentiated, whereas 
CLZ showed a progressively attenuated disruption (all ps < 0.05).
disrupted various active components of maternal behavior. Rats 
treated with HAL and CLZ took a much longer time to approach and 
retrieve their pups into the nest sites (data not shown) and retrieved 
less pups at 2 h and 4 h testing points (all ps < 0.05). They also spent 
less time on pup licking and nest building (One-way ANOVA and 
LSD post hoc test, all ps < 0.05). However, nursing activity was not 
significantly affected by any drug treatment. CDP only impaired 
nest building (p < 0.01 for 2 h, p < 0.05 for 4 h), suggesting that this 
behavior may be more vulnerable than others to the disruptive effect 
of drug treatment.
3.1.2.Pup-separation shortened pup approach latency and increased pup 
licking and pup nursing, but failed to reverse pup retrieval deficit
To examine the effects of pup-separation on maternal behavior 
under the influence of antipsychotics, we compared the maternal 
behavior data obtained under the pup-separation condition from 
Days 4 and 6 postpartum with those obtained under the no-pup-
separation condition from both days. Once again, in comparison 
to the vehicle, HAL disrupted pup retrieval and CLZ inhibited the 
dams’ approach and retrieval of their pups in this data set. Pup-sep-
aration significantly shortened CLZ-treated pup approach latency 
(Table 1) but failed to alleviate the pup retrieval deficits, as there was 
no significant improvement in the first and last pup retrieval latency 
(Table 1) and in the number of pups retrieved (Figure 2A). Repeated 
measures ANOVA on the number of pups retrieved revealed a sig-
nificant main effect of drug treatment [F(3,42) = 14.58, p = 0.000 for 2 h; 
F(3,42) = 11.68, p = 0.000 for 4 h], but no significant effect of separation 
or interaction between the drug treatment and pup-separation. Pup-
separation also did not affect the nest building activity (Figure 2C). 
Repeated measures ANOVA revealed a main effect of drug treat-
ment [F(3,42) = 28.64, p = 0.000 for 2 h; F(3,42) = 16.79, p = 0.000 for 4 h], 
but no significant effect of separation or interaction between the two 
factors.
Most prominently, pup-separation did substantially increase the 
amount of time spent by the mothers on licking (Figure 2B) and nurs-
ing (Figure 2D). For pup licking, repeated measures ANOVA revealed 
a main effect of drug treatment [F(3,42) = 6.43, p = 0.001], a significant 
effect of separation [F(1,42) = 36.07, p < 0.001], and a significant interac-
tion between the two factors [F(3,42) = 3.29, p = 0.030] at the 2 h testing 
point. Two-group comparisons (or one-way ANOVA) revealed that 
pup-separation consistently enhanced duration of pup licking across 
all treatment groups at the 2 h point (p < 0.01 for VEH and CDP, 
p < 0.05 for HAL and CLZ). For pup nursing, repeated measures 
ANOVA revealed a significant effect of separation [F(1,42) = 32.03, p 
= 0.000], but no main effect of drug treatment or significant interac-
tion between the two factors at the 2 h point. Further analysis with
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3.2.4. Nest building
Repeated measures ANOVA revealed a main effect of drug treat-
ment (all ps < 0.001), no significant effect of test day, but a significant 
interaction between the two factors (all ps < 0.05) at 1 h, 2 h, and 4 
h testing points; there was a main effect of drug treatment [F(3,40) 
= 12.27, p = 0.045], a significant effect of test time [F(2,80) = 6.57, p 
= 0.002], but no significant interaction between the two factors at 
the baseline level. Post hoc tests showed that HAL significantly dis-
rupted nest building activity at 1 h, 2 h, 4 h testing points (all ps < 
0.05) across the three test days, at the baseline on Day 10 (p = 0.013) 
and Day 12 postpartum (p = 0.015); whereas CLZ impaired pup 
retrieval at 1 h and 2 h across the test days (all ps < 0.05) and at 4 h 
3.2.3. Pup licking
Repeated measures ANOVA revealed a main effect of drug treat-
ment [F(3,40) = 12.36, p < 0.001 for 1 h; F(3,40) = 17.80, p < 0.001 for 2 
h], no significant effect of test time or significant interaction between 
the two factors at 1 h or 2 h testing point. Post hoc tests showed that 
HAL significantly impaired pup licking activity at 2 h post-injection 
(both ps < 0.05), while CLZ did so at 1 h and 2 h on Day 10 and Day 
12 postpartum (both ps < 0.05). As opposed to HAL and CLZ, CDP 
produced a significant enhancing effect on pup licking at 1 h and 2 
h testing points on Day 8 postpartum (both ps < 0.05). No long-term 
potentiation or attenuation of the drug effect on pup licking activity 
was observed (Paired Samples T test, Day 8 vs Day 12, all ps > 0.05).
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ment [F(3,40) = 15.14, p < 0.001 for 1 h; F(3,40) = 7.02, p = 0.001 for 2 h; F(3,40) 
= 16.45, p = 0.019 for 4 h], a main effect of test time [F(2,80) = 4.11, p = 
0.020 for 1 h; F(2,80) = 9.78, p < 0.001 for 2 h; F(2,80) = 4.78, p = 0.011 for 
4 h], but no significant interaction between the two factors at 1 h, 2 
h and 4 h testing points; there was a main effect of drug treatment 
[F(3,40) = 3.21, p = 0.033] but no significant effect of test time or signif-
icant interaction between the two factors at the baseline level. Post 
hoc tests showed that there were no consistent effects among the 
different drug conditions on nursing activity (Figure 3D). The same 
(p = 0.014) on Day 8 postpartum only. In particular, CDP produced 
a disruptive effect on this behavior similar but somewhat weaker 
than that of HAL and CLZ (all ps < 0.05). Long-term potentiation 
of the drug effect was observed (Day 8 vs Day 12 Paired Samples T 
test, p< 0.05).
3.2.5. Pup nursing
Repeated measures ANOVA revealed a main effect of drug treat-
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attributable to the motivation-enhancing effect of pup-separation. 
In addition, with the repeated drug treatment, we showed that HAL 
progressively impaired active components of maternal responses 
(e.g., pup approach, pup retrieval and nest building), while HAL-
induced sedation was diminished across the test period. In con-
trast, the magnitude of both the disruptive and sedative effects of 
CLZ was reduced throughout the postpartum period, suggesting 
that the CLZ-induced disruption in pup retrieval may be partially 
attributed to its sedative side effect.
It is well documented that acutely administered antipsychotics 
disrupt active maternal behavior in rats, but generally have little 
effect, or even an enhancing effect on pup nursing (Giordano et al., 
1990; Li et al., 2004a; Silva et al., 2001; Stern and Taylor, 1991). How-
ever the exact behavioral mechanisms underlying such an effect are 
not entirely clear. In the present study, we explored the possibil-
ity that antipsychotic-induced maternal behavior deficits may pri-
marily reflect an inhibition on maternal motivation, an action that 
is likely mediated by antipsychotics’ common antagonistic effect 
on dopamine D2 receptors (Kapur and Mamo, 2003). Toward this 
end, we employed a pup-separation technique because mother-
pup separation has been shown to enhance maternal motivation in 
the postpartum rats (Hansen, 1994; Hansen et al., 1993). This idea 
is based on the finding that separation of the lactating rats with 
6-OHDA lesions in the ventral striatum from their pups for 3-6 h 
shortened their pup retrieval latency (Hansen, 1994). We reasoned 
that if pup-separation is able to antagonize the effect of dopamine 
blockade of the antipsychotics, it would suggest that the disruptive 
drug effect is mainly exerted on animals’ motivation rather than 
on their motoric functions. To the best of our knowledge, there is 
no study that has directly compared the effect of pup-separation 
on the antipsychotic-induced maternal behavior deficits. We found 
that pup-separation significantly shortened clozapine-elongated 
approach latency, and increased pup licking in lactating dams, the 
most frequently observed pup-directed active behavior (Lonstein et 
al., 1999), while facilitating quiescent nursing activity (Stern, 1991; 
Stern and Taylor, 1991). These findings strongly suggest that pup-
separation is capable of reversing some maternal behavior deficits 
to a certain extent, which in turn, indicates that antipsychotics may 
disrupt maternal behavior by inhibiting mothers’ motivation to 
take care of the young, not simply impairing their motor functions. 
This point is also supported by the findings from Stern and Tay-
lor (1991) and Li et al. (2004a). Stern and Taylor (1991) reported that 
HAL at 0.2 mg/kg, a dose much higher than ours (HAL at 0.1 mg/
kg), did not produce any disruption of pup retrieval, whereas Li et 
al. (2004a) found that it did. Our current study found that HAL even 
at 0.1 mg/kg produced a significant impairment on pup retrieval 
when rats were tested under the regular, no-pup-separation con-
dition. One reason for this different result may lie in the fact that
drug produced an opposite effect at distinct test points or test days.
For instance, HAL increased duration of pup nursing at the 1 h test-
ing point on Day 10 and Day 12 postpartum, as well as 2 h on Day 
12 postpartum, whereas it suppressed this behavior at 4 h on Day 8 
postpartum. Also, CLZ enhanced this activity at baseline on Day 12 
postpartum but reduced it at 2 h on Day 10 postpartum. Noticeably, 
CDP produced a prominent enhancing effect on the nursing behav-
ior. Long-term potentiation of the drug effect was observed (Day 8 
vs Day 12 Paired Samples T test, all ps < 0.05).
3.2.6. Repeated antipsychotic treatment induced an attenuated sedation
Figure 4 depicts the sedation scores of repeated treatment with 
HAL, CLZ, CDP, and vehicle over the four test sessions each day 
over the three test days. The sedative effect of HAL and CLZ tended 
to diminish over the testing period, whereas CDP at the present dose 
did not produce a noticeable sedation. Further analysis with Mann-
Whitney U test showed that in comparison to the vehicle treatment, 
HAL induced a mild sedative effect at the 2 h post-injection testing 
point across the test days, whereas CLZ produced moderate seda-
tion at 1 h and 2 h on Day 8, and at 2 h only on Day 10. Long-term 
alleviation of the drug sedative effect was observed (Day 8 vs Day 
12 Wilcoxon’s Two Related Samples Tests, all ps < 0.05). To examine 
to what extent that drug-induced sedation may contribute to the dis-
ruption on maternal behavior, we assessed the correlation between 
the disruptive effect of HAL and CLZ on the number of pups 
retrieved as a representative parameter of active maternl behaviors 
and the sedation scores of these drugs at the 2 h testing point from 
Day 8 to 12. We chose the 2 h point as the representation of the drug 
effect because the present and previous studies show that after a sin-
gle injection of HAL and CLZ (Li et al., 2004a), the drug effects peak 
at 1-2 h post-injection. Spearman rank correlation analysis revealed 
that the disruptive effect of CLZ was strongly correlated with its sed-
ative effect (Rs = 0.502, p = 0.002), whereas HAL-induced disruption 
was not correlated with its sedation (Rs = 0.039, p = 0.830). These 
results demonstrate that HAL-induced disruptive effect on active 
maternal behavior (number of pups retrieved) is mainly attributable 
to its effect of dopamine blockade but not sedation of the drug, but 
CLZ’s sedative effect is at least in part responsible for CLZ-induced 
disruption on this active maternal behavior.
4. Discussion
In the present study, we showed that acute and chronic treat-
ment with HAL and CLZ disrupted active maternal behaviors 
(e.g., pup retrieval, pup licking and nest building) in the post-
partum female rats. More importantly, using the pup-separa-
tion technique, we found that separation of the pups from their 
mothers for 4 h before testing significantly enhanced pup lick-
ing activity and stimulated nursing behavior, an effect most likely
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started to lick the pups while adopting a hovering posture over the 
pups. However, for the antipsychotic-treated rats, after the pups 
were placed into the test cages, the dams often promptly com-
menced to lick them at the corner where the pups were placed, failed 
to retrieve them back to the nest site. This may explain why pup-sep-
aration had less of an effect on reversing the pup retrieval deficit-
induced by antipsychotic treatment. We also failed to observe any 
effect of pup-separation on antipsychotic-induced disruption in nest 
building. During the 8-min pup retrieval session, we noted that after 
reunion with the pups, the mother rats spent most of their time on 
retrieving, licking and nursing pups, and spent less time on rebuild-
ing the nest. The disrupted nest building behavior is not so easy to be 
restored relative to pup licking and pup retrieval is consistent with 
our previous observation that nest building activity is one compo-
nent of rat maternal behavior most sensitive and vulnerable to phar-
macological disturbance (Li et al., 2004a, 2005a; Silva et al.,2001).
To address whether and to what extent antipsychotic drug-induced 
sedation is associated with their disruption on active maternal 
behavior, we employed a repeated treatment regimen and recorded 
the sedation scores along with maternal performance. We also com-
pared the effects of HAL and CLZ with CDP, an anxiolytic drug with 
sedative effect. Because sedation tends to dissipate with repeated 
drug treatment (Chesler and Salamone, 1996; File, 1984; Salamone 
et al., 1996), we reasoned that if it is a contributing factor, we would 
expect to see more severe disruption on maternal behavior at the 
early stage of testing than the later. Data from Days 8, 10 and 12 post-
partum indicate that with repeated drug administration, HAL and 
CLZ produced differential pattern of drug effect on active mater-
nal behavior. HAL induced a sustained disruption on active compo-
nent of maternal behavior throughout the drug treatment period in 
the background of a diminished seative effect. This observation dis-
counts the sedation explanation for the disruptive effect of HAL. For 
CLZ, we found that both its disruptive effect on maternal behavior 
(e.g. pup retrieval) and its sedative effect were attenuated with the 
repeated drug administration and there was a significant correlation 
between the two, suggesting the CLZ-induced sedation may contrib-
ute to its disruptive effect on maternal behavior. It should be noted 
that animals used in the repeated treatment test were not experimen-
tally or pharmacologically naïve at the start of the experiment. We 
could not rule out the potential carry-over effects produced by the 
previous drug administration or separation manipulation. There is a 
possibility that unmanipulated and drug-naïve animals would have 
had somewhat different behavioral profiles in Experiment 2. Future 
work using naïve animals and testing them for more days may help 
answer this question.
In the present study, we chose CDP as a pharmacological con-
trol to examine the specificity of antipsychotics’ effect on maternal 
behavior. CDP, similar to atypical CLZ, also gives rise to sedation 
(File, 1984) but lacks the antipsychotic effect. We hypothesize that 
if the disruptive effect on maternal motivation is specific to antip-
sychotic drugs, we expect that CDP would not significantly dis-
rupt active maternal behaviors but produce sedative effect to some 
extent. Surprisingly, we were unable to detect evident sedation 
induced by CDP at 5.0 mg/kg, while others have shown it does (File, 
1984). One possible explanation for the discrepancy may be due to 
methodological difference. In the previous work, the sedative effect 
of CDP was assessed by quantifying locomotor activity and explo-
ration (File, 1984), while we measured sedation according to a seda-
tion rating (Chesler and Salamone, 1996) in which locomotor activity 
and exploration were not quantitatively analyzed. We cannot com-
pletely exclude the possibility of reduced locomotor activity and 
exploration after CDP treatment, if any, in the present study as pre-
viously observed by File (1984). Another reason for the discrepancy 
may be the different subjects used in the two studies. Of note, lactat-
ing rats were used in the present study as opposed to male animals 
in the previous work. Reduced emotional and neuroendocrine stress 
responses such as reduced anxiety and fear have been described in 
lactation (Neumann et al., 2000; Windle et al., 1997). It is possible that 
the reduced anxious and fearful responses may make the lactating 
Stern and Taylor (1991) tested their rats under a 4-h mother-pup 
separation condition, whereas Li et al. (2004a) tested rats under the 
regular (no-pup-separation condition). The current finding show-
ing that antipsychotic-treated rats responded to their pups differ-
ently under the separation and no-separation condition is consis-
tent with this explanation.
Contrary to our results, a similar study using pup-separation 
skill showed that demanding pups (pups that remained separated 
from their mothers for 12 h before testing) significantly reversed all 
the deficits of active components of maternal behaviors (e.g., pup 
retrieval, mouthing, pup licking and nest building) in HAL-treated 
lactating females (Pereira and Ferreira, 2006). The different effects 
of pup-separation on HAL-induced maternal behavior impairments 
between the two studies may be due to the methodological differ-
ences. These differences include the HAL dose (0.05 mg/kg vs 0.1 
mg/kg), duration of separation (12 h vs 4 h), testing duration (30 
min vs 8 min), etc. In addition, in that study, the mother rats were 
not separated from their litters until 15 min before testing and were 
tested with donor pups that were isolated for 12 h, whereas in this 
present study, our subjects were separated from their own pups 
and tested with their own pups. Taken together the findings from 
both studies, it is interesting to speculate that a 12-h separation is 
more effective in stimulating maternal motivation and overcoming 
the impairments induced by a lower dose of HAL (0.05 mg/kg).
There are several possible factors associated with pup-separation 
that may increase maternal motivation and contribute to the differ-
ent maternal performance observed under the pup-separation and 
no-separation condition. One possible factor is the increase of incen-
tive value of separated pups. After an extended separation (~4 h), 
pups are in acute need of active maternal care because they are hun-
gry and they also need mothers to provide anogenital stimulation to 
help them urinate and defecate (Brouette-Lahlou et al., 1992). Also, 
separated pups may attract the mother rat’s attention by emitting 
more audible and ultrasonic vocalizations (Brouette-Lahlou et al., 
1992; Hofer, 1973; Iijima and Chaki, 2005; Polan and Hofer, 1999). 
Another possible factor is the change of physical condition of sep-
arated mothers. After a prolonged separation, milk engorgement of 
the mammary glands in dams may stimulate mother rats to approach 
to the sensory cues emitted by the pups and thereby increase their 
maternal performance. Previous work has shown two to three min-
utes separation is less effective in improving pup retrieval than a 
4-6 h separation because shorter separation doses not allow suffi-
cient distention of mammary glands (Hansen, 1994). Moreover, 
the degree of maternal responses to pups is found to be correlated 
with duration of separation from pups (Hansen, 1994). Given that 
dopamine plays an essential role in regulating maternal motiva-
tion through the mesolimbic dopamine system (Byrnes et al., 2002; 
Hansen et al., 1991b; McCullough et al., 1993; Miller and Lonstein, 
2005; Numan et al., 2005; Robbins and Everitt, 1996), it is conceiv-
able that separation-facilitated pup licking may be associated with 
an increase in mesolimbic dopamine release. This idea is consistent 
with the finding that the increase in dopamine level in the nucleus 
accumbens shell is significantly correlated with the magnitude and 
duration of the licking bout (Champagne et al., 2004). This hypoth-
esis is further supported by earlier studies showing that dopamine 
receptor blockade in the nucleus accumbens disrupted pup licking 
(Keer and Stern, 1999; Stern and Lonstein, 2001), and reunion with 
separated pups significantly increases dopamine release in the ven-
tral striatum of maternal rats (Hansen et al., 1993), and blockade of 
dopamine neurotransmission by haloperidol decreases exploratory 
behavior as measured by the reduced percentage of time spent in 
the open arms of the maze, whereas the presence of the pups in the 
open arms of the maze override such deficits provoked by haloperi-
dol (Pereira et al., 2005).
In contrast to our expectation, pup-separation failed to reverse 
the antipsychotic-induced disruption of pup retrieval. We often 
observed that after reunion with the pups, the vehicle-treated rats 
rapidly approached and retrieved the pups into the nest site then 
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subjects less sensitive to the anxiolytic drugs (e.g., CDP). Earlier evi-
dence in favor of this view came from the findings that the anti-anx-
iety effect of a serotonergic agonist, 8-hydroxy-2 (di-n-propylamino) 
tetralin (8-OH-DPAT) were completely absent in 7-day lactating rats 
(Fernández-Guasti et al., 1998; Picazo et al., 2000). Further study is 
needed to address this issue and determine whether CDP induces 
sedation in lactating rats and if it does, whether this sedative effect is 
less severe in lactating rats than male rats.
Finally, the relation between motor function and motiva-
tional processes is an additional point to consider in the pres-
ent work. Because dopamine is closely associated with motor 
and motivational functions, and motor activity is an impor-
tant feature of motivated behavior (Salamom ,ne, 1987, 1988), 
it is somewhat difficult to draw a hard and fast line between motor 
and motivational systems in the brain. It has been argued that the 
motor and motivational processes overlap considerably and share 
some common mechanisms of regulation (Salamone, 1987, 1988, 
1991, 1992; Salamone et al., 1989). In support of this view, our data 
reveal that some impairments of active maternal behavior are more 
easily reversible (e.g., pup licking), while others are not (e.g., nest 
building), suggesting that not all the motivated behaviors impaired 
by HAL and CLZ are equally restored with motivational manipula-
tions (pup-separation).
In summary, the present study shows that the disruptive effect 
of antipsychotics on maternal behavior at least in part reflects its 
suppressive effect on maternal motivation as pup-separation sig-
nificantly increases pup licking activity, one active component of 
maternal motivation. In addition, our repeated drug testing data 
also reveal that CLZ’s sedative effect is also involved in its disrup-
tive effect on maternal behavior. The fact that CDP did not impair 
maternal behavior except nest building suggests that antipsychotic-
induced deficits may reflect a common effect of dopamine blockade 
(Li et al., 2004a). These findings suggest that behavioral techniques 
aimed at increasing maternal motivation may help alleviate the neg-
ative side effects of antipsychotic treatment on maternal behavior.
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